Literature DB >> 29492681

Clinical Management of Episodic Memory Changes in Dementia.

Po-Heng Tsai1.   

Abstract

PURPOSE OF REVIEW: The purpose of this review was to discuss therapeutic options available for the treatment of memory difficulties in dementia. RECENT
FINDINGS: Because of the lack of progress in the availability of new medications, there has been an increased interest in focusing on non-pharmacological means to management cognitive symptoms related to dementia. The clinical management of memory loss should focus both on pharmacological and non-pharmacological approaches. Treatment with medications should usually begin with a cholinesterase inhibitor and then followed by addition of memantine if there is a decline. In addition to medication management, emphasis should be placed on the importance of maintaining a healthy lifestyle that encompasses physical activities, cognitive stimulation, and a healthy diet.

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Mediterranean diet; Non-pharmacological; Physical activities; Treatment

Year:  2018        PMID: 29492681     DOI: 10.1007/s11940-018-0491-8

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  42 in total

1.  Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

Authors:  C Courtney; D Farrell; R Gray; R Hills; L Lynch; E Sellwood; S Edwards; W Hardyman; J Raftery; P Crome; C Lendon; H Shaw; P Bentham
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

Review 2.  Cerebrovascular reserve: the link between fitness and cognitive function?

Authors:  Margie H Davenport; David B Hogan; Gail A Eskes; R Stewart Longman; Marc J Poulin
Journal:  Exerc Sport Sci Rev       Date:  2012-07       Impact factor: 6.230

Review 3.  Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review of the Evidence.

Authors:  Sara Danuta Petersson; Elena Philippou
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

4.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

5.  Mediterranean diet, Alzheimer disease, and vascular mediation.

Authors:  Nikolaos Scarmeas; Yaakov Stern; Richard Mayeux; Jose A Luchsinger
Journal:  Arch Neurol       Date:  2006-10-09

6.  Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease.

Authors:  Howard H Feldman; Tuula Pirttila; Jean François Dartigues; Brian Everitt; Bart Van Baelen; Susanne Schwalen; Shane Kavanagh
Journal:  Int J Geriatr Psychiatry       Date:  2009-05       Impact factor: 3.485

7.  Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Authors:  Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

8.  Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease.

Authors:  Carolyn W Zhu; Elayne E Livote; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2013-01-17       Impact factor: 21.566

9.  Relative tolerability of Alzheimer's disease treatments.

Authors:  Gustavo Alva; Jeffrey L Cummings
Journal:  Psychiatry (Edgmont)       Date:  2008-11

10.  Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.

Authors:  Cyrus A Raji; David A Merrill; Harris Eyre; Sravya Mallam; Nare Torosyan; Kirk I Erickson; Oscar L Lopez; James T Becker; Owen T Carmichael; H Michael Gach; Paul M Thompson; W T Longstreth; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.